Sanofi Has EU Insulin Aspart Biosimilar Approval

Firm Comments on Pricing And Launch Plans For Rival To NovoRapid

 
• By Dave Wallace

Sanofi has received formal approval from the European Commission for its insulin aspart biosimilar.

Thumbs_Up_EU
The European Commission has formally approved Sanofi’s insulin aspart biosimilar • Source: Shutterstock

More from Biosimilars

More from Products